Global Immunoglobulin Market Report 2021: COVID-19


New York, September 20, 2021 (GLOBE NEWSWIRE) – announces the publication of the report “Immunoglobulins Global Market Report 2021: COVID-19 Implications And Growth” – Utm_source = GNW

The global immunoglobulin market is expected to grow from $ 12.89 billion in 2020 to $ 14.56 billion in 2021 at a compound annual growth rate (CAGR) of 13%. The change in growth trend is mainly due to companies stabilizing production after meeting demand that increased exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $ 19.36 billion in 2020. 2025 at a CAGR of 7.4%.

The immunoglobulin market consists of the sales of immunoglobulins by entities (organizations, sole proprietorships, and partnerships) which are used to measure the level of types of antibodies in the blood. Immunoglobulins or antibodies are glycoprotein molecules generated by plasma cells (white blood cells).

They are an important aspect of the immune response because they recognize and bind to certain antigens, such as bacteria or viruses, and help destroy them.

The main types of products contained in immunoglobulins are IGG, IGA, IGM, IGE and IGD. Immunoglobulin G (IGG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph and saliva.

Immunoglobulins are administered using the intravenous mode of administration, the subcutaneous mode of administration and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, purpura idiopathic thrombocytopenic (ITP), others.

North America was the largest region of the immunoglobulin market in 2020. Asia-Pacific is expected to be the fastest growing region during the forecast period.

The regions covered in this report are Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East & Africa.

The launch of new offices and laboratories to stimulate research and development activities is shaping the immunoglobulin market. Leading companies operating in the immunoglobulin industry are focused on opening new laboratories for immunoglobulins to improve platform technology, pipeline development and manufacturing capabilities.

For example, in February 2021, VectorY, a fully integrated gene therapy company, opened offices and laboratories in the Netherlands to develop new vectorized antibodies for muscle and neurological diseases. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV. antibody-based targeted degradation platform and technology.

The company is developing a pipeline of novel vectorized antibodies to treat muscle and CNS diseases, to improve delivery, durability and accessibility of specific tissues and cells, to overcome the limitations of current therapies.

In June 2020, CSL Behring, a US-based biopharmaceutical company, acquired Vitaeris Inc. for an undisclosed amount. This acquisition accelerates the addition of clazakizumab, an anti-IL6 MAB currently in phase III development for the treatment of chronic active antibody-induced rejection, to the CSL Behring portfolio. Vitaeris Inc. is an American clinical-stage biotechnology company.

The increase in the geriatric population is driving the growth of the immunoglobulin market. The geriatric population is at high risk of infectious and autoimmune diseases.

The immunoglobulin test determines the body’s ability to produce antibodies that protect it from bacteria, viruses and allergies. According to the United Nations Department of Economic and Social Affairs (UN DESA), in 2020 the number of people over the age of 65 was 727 million. at the World level.

By 2050, that figure is expected to more than double, reaching more than 1.5 billion people. The aging population is expected to increase from 9.3% in 2020 to 16% in 2050. Thus, the increase in the geriatric population is expected to increase the demand for the immunoglobulin market during the forecast period.

Countries Covered in Immunoglobulin Market Report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom United and the United States.
Read the full report:

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Leave A Reply

Your email address will not be published.